N-3 fatty acids: priority for post-myocardial infarction clinical trials

Circulation. 2003 Apr 15;107(14):1834-6. doi: 10.1161/01.CIR.0000059746.10326.09.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anti-Arrhythmia Agents / administration & dosage
  • Anti-Arrhythmia Agents / therapeutic use
  • Cardiovascular Diseases / prevention & control*
  • Clinical Trials as Topic
  • Dietary Supplements*
  • Eating
  • Fatty Acids, Omega-3 / administration & dosage
  • Fatty Acids, Omega-3 / therapeutic use*
  • Humans
  • Myocardial Infarction / prevention & control*
  • Secondary Prevention

Substances

  • Anti-Arrhythmia Agents
  • Fatty Acids, Omega-3